These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37593226)

  • 21. Mediating Effects of Technology-Based Therapy on the Relationship Between Socioeconomic Status and Glycemic Management in Pediatric Type 1 Diabetes.
    Stanley JR; Clarke ABM; Shulman R; Mahmud FH
    Diabetes Technol Ther; 2023 Mar; 25(3):186-193. PubMed ID: 36409503
    [No Abstract]   [Full Text] [Related]  

  • 22. Association Between Adherence, A1C Improvement, and Type of Continuous Glucose Monitoring System in People with Type 1 Diabetes or Type 2 Diabetes Treated with Intensive Insulin Therapy.
    Nemlekar PM; Hannah KL; Green CR; Norman GJ
    Diabetes Ther; 2024 Mar; 15(3):639-648. PubMed ID: 38289464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time In Range in Children with Type 1 Diabetes Using Treatment Strategies Based on Nonautomated Insulin Delivery Systems in the Real World.
    Cherubini V; Bonfanti R; Casertano A; De Nitto E; Iannilli A; Lombardo F; Maltoni G; Marigliano M; Bassi M; Minuto N; Mozzillo E; Rabbone I; Rapini N; Rigamonti A; Salzano G; Scaramuzza A; Schiaffini R; Tinti D; Toni S; Zagaroli L; Zucchini S; Maffeis C; Gesuita R
    Diabetes Technol Ther; 2020 Jul; 22(7):509-515. PubMed ID: 32073311
    [No Abstract]   [Full Text] [Related]  

  • 25. Lower Glycated Hemoglobin with Real-Time Continuous Glucose Monitoring Than with Intermittently Scanned Continuous Glucose Monitoring After 1 Year: The CORRIDA LIFE Study.
    Radovnická L; Hásková A; Do QD; Horová E; Navrátilová V; Mikeš O; Cihlář D; Parkin CG; Grunberger G; Prázný M; Šoupal J
    Diabetes Technol Ther; 2022 Dec; 24(12):859-867. PubMed ID: 36037056
    [No Abstract]   [Full Text] [Related]  

  • 26. When Low Blood Sugars Cause High Anxiety: Fear of Hypoglycemia Among Parents of Youth With Type 1 Diabetes Mellitus.
    Abitbol L; Palmert MR
    Can J Diabetes; 2021 Jul; 45(5):403-410.e2. PubMed ID: 33046404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: A narrative review.
    Speight J; Choudhary P; Wilmot EG; Hendrieckx C; Forde H; Cheung WY; Crabtree T; Millar B; Traviss-Turner G; Hill A; Ajjan RA
    Diabet Med; 2023 Jan; 40(1):e14944. PubMed ID: 36004676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in Health Care Utilization.
    Parkin CG; Graham C; Smolskis J
    J Diabetes Sci Technol; 2017 May; 11(3):522-528. PubMed ID: 28745091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures.
    Thomas MG; Avari P; Godsland IF; Lett AM; Reddy M; Oliver N
    Diabetes Obes Metab; 2021 Nov; 23(11):2521-2528. PubMed ID: 34286892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Higher scanning frequency is correlated with less fear of hypoglycemia in type 1 diabetes patients using isCGM.
    Hohendorff J; Witek P; Kania M; Sudol M; Hajduk K; Stepien A; Cyganek K; Kiec-Wilk B; Klupa T; Malecki MT
    Front Endocrinol (Lausanne); 2022; 13():996933. PubMed ID: 36277730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.
    Hemmingsen B; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013498. PubMed ID: 33662147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
    Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
    Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological characterization of diabetic patients on therapy with continuous subcutaneous insulin infusion and continuous glucose monitoring in real time.
    Aristizábal N; Ramírez A; Hincapié-García J; Laiton E; Aristizábal C; Cuesta D; Monsalve C; Hincapié G; Zapata E; Abad V; Delgado MR; Torres JL; Palacio A; Botero J;
    Endocrinol Nutr; 2015 Nov; 62(9):451-7. PubMed ID: 26521154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
    Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
    Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toward defining a cutoff score for elevated fear of hypoglycemia on the hypoglycemia fear survey worry subscale in patients with type 2 diabetes.
    Hajós TR; Polonsky WH; Pouwer F; Gonder-Frederick L; Snoek FJ
    Diabetes Care; 2014; 37(1):102-8. PubMed ID: 23990513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
    Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fear of hypoglycaemia and its relation to hypoglycaemia awareness and symptom intensity in Type 1 diabetes.
    Hatle H; Bjørgaas MR; Rø TB; Olsen SE; Åsvold BO
    Diabetes Res Clin Pract; 2018 Mar; 137():213-220. PubMed ID: 29407272
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.